These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8352614)

  • 1. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany.
    Rzany B; Mockenhaupt M; Stocker U; Hamouda O; Schöpf E
    Arch Dermatol; 1993 Aug; 129(8):1059. PubMed ID: 8352614
    [No Abstract]   [Full Text] [Related]  

  • 2. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection.
    Porteous DM; Berger TG
    Arch Dermatol; 1991 May; 127(5):740-1. PubMed ID: 1827245
    [No Abstract]   [Full Text] [Related]  

  • 6. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fritsch P
    Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404
    [No Abstract]   [Full Text] [Related]  

  • 7. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
    Kelly JP; Kaufman DW; Dunant A; Mockenhaupt M; Roujeau JC
    J Am Acad Dermatol; 2011 Jun; 64(6):1193-4. PubMed ID: 21571188
    [No Abstract]   [Full Text] [Related]  

  • 9. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    de Rego JA; Goldstein DM
    Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis and toxic epidermal necrolysis or Stevens-Johnson syndrome after nonmucosal topical drug application: fact or fiction?
    Sachs B; Fischer-Barth W; Erdmann S; Merk HF; Seebeck J
    Allergy; 2007 Aug; 62(8):877-83. PubMed ID: 17620064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early gynaecological assessment following Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Madhuri TK; Kremer C
    J Obstet Gynaecol; 2010; 30(8):871-2. PubMed ID: 21126137
    [No Abstract]   [Full Text] [Related]  

  • 12. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
    Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
    J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Lee HY; Pang SM; Thamotharampillai T
    J Am Acad Dermatol; 2008 Aug; 59(2):352-3. PubMed ID: 18638633
    [No Abstract]   [Full Text] [Related]  

  • 14. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E
    Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of severe ocular complications of stevens-johnson syndrome and toxic epidermal necrolysis.
    Sotozono C; Ueta M; Kinoshita S
    Arch Dermatol; 2009 Nov; 145(11):1336-7; author reply 1337-8. PubMed ID: 19917974
    [No Abstract]   [Full Text] [Related]  

  • 16. [Considerations on a case of toxic epidermic necrolysis (Lyell's syndrome) with Stevens-Johnson pluriorificial syndrome].
    Cislaghi F; Pagliano Sassi L; Moreno A
    Minerva Pediatr; 1967 Mar; 19(12):540-2. PubMed ID: 5607236
    [No Abstract]   [Full Text] [Related]  

  • 17. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stevens-Johnson syndrome and toxic epidermal necrolysis in Togo: the role of self-medication].
    Saka B; Kombaté K; Egbohou P; Mouhari-Toure A; Akakpo S; Boukari T; Tchangaï-Walla K; Pitché P
    Ann Dermatol Venereol; 2012 Jun; 139(6-7):486-7. PubMed ID: 22721483
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxic epidermal necrolysis and Steven-Johnson syndrome in oncologic patients.
    Gravante G; Delogu D; Marianetti M; Esposito G; Montone A
    Eur Rev Med Pharmacol Sci; 2007; 11(4):269-74. PubMed ID: 17876963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.
    Schneck J; Fagot JP; Sekula P; Sassolas B; Roujeau JC; Mockenhaupt M
    J Am Acad Dermatol; 2008 Jan; 58(1):33-40. PubMed ID: 17919775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.